Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey

Hüls, Anke; C. S. Costa, Alberto; Dierssen, Mara; Asaad Baksh, R.; Bargagna, Stefania; Baumer, Nicole; Cláudia Brandão, Ana; Carfì, Angelo; Carmona‐Iragui, María; Chicoine, Brian; Ghosh, Sujay; Lakhanpaul, Monica; Manso, Coral; Ángel Mayer, Miguel; Ortega, M; Real de Asúa, Diego; Rebillat, Anne‐Sophie; Russell, Lauren; Sgandurra, Giuseppina; Valentini, Diletta; L. Sherman, Stephanie; Strydom, André

doi:10.1016/j.eclinm.2021.100769

Public

Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey

Published in EClinicalMedicine • Feb 22, 2021

Authors:

Anke Hüls

Alberto C. S. Costa

Mara Dierssen

Abstract

Background Health conditions, immune dysfunction, and premature aging associated with trisomy 21 (Down syndrome, DS) may impact the clinical course of COVID-19. Methods The T21RS COVID-19 Initiative launched an international survey for clinicians or caregivers on patients with COVID-19 and DS. Data ...

Subject

Medicine

Coronavirus disease 2019 (COVID-19)

Trisomy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!